Investment
Features
FeesSafety
Academy
More
Pluang+

Traditional payment firms and crypto startups increasingly partner on cards, stablecoins, and settlements by 2026.

Market News
19 Jul 2026
Crypto news
View Source
Bullish
pluang ai news

A 2014 prediction about traditional payment companies collaborating with Bitcoin startups is now reality, as firms like Visa and Mastercard actively work with crypto companies on payment cards, stablecoins, and settlement systems. BitPay, a pioneer in regulated crypto payments, continues to expand its services in Europe following new authorizations. The payments industry has shifted focus from Bitcoin alone to stablecoins, with major players backing initiatives like the Open USD stablecoin to build blockchain payment infrastructure. These partnerships have evolved from early experiments into mainstream payment solutions expected to grow through 2026 and beyond.

More News

Axsome Therapeutics gets 'Outperform' rating on strong drug pipeline and FDA NDA acceptance for narcolepsy drug.

Axsome Therapeutics gets 'Outperform' rating on strong drug pipeline and FDA NDA acceptance for narcolepsy drug.

Axsome Therapeutics received an "Outperform" rating from BMO Capital due to significant progress in its drug pipeline, including FDA acceptance of its NDA for AXS-12, a narcolepsy treatment with a PDUFA date set for May 1, 2027. The company is also a...

Analyst Insights
Bullish
2 hours ago
Novartis Q2 earnings expected at $2.17 EPS, $14.07B revenue amid patent loss impact and key drug trials ahead.

Novartis Q2 earnings expected at $2.17 EPS, $14.07B revenue amid patent loss impact and key drug trials ahead.

Novartis is set to report its Q2 earnings with analysts expecting an EPS of $2.17 and revenue of $14.07 billion, following a tough Q1 affected by major patent expirations. Despite revenue challenges, the company maintained strong cash flow of $3.30 b...

Company Fundamentals
Neutral
3 hours ago
KeyCorp expects 20% EPS growth driven by strong loan demand and rising net interest income.

KeyCorp expects 20% EPS growth driven by strong loan demand and rising net interest income.

KeyCorp is set to report earnings with analysts forecasting a 20% increase in earnings per share to $0.42 and an 8% rise in total revenue to $1.97 billion. The growth is mainly driven by a 10% increase in net interest income, fueled by strong commerc...

Company Fundamentals
Bullish
4 hours ago
Biotech and manufacturing stocks plunge after major company shifts and financial concerns.

Biotech and manufacturing stocks plunge after major company shifts and financial concerns.

Several biotech and manufacturing companies saw significant stock declines due to key corporate events. Vision Marine Technologies dropped nearly 24% after shifting its focus from boat manufacturing to a mining project, causing investor uncertainty. ...

Market News
Bearish
4 hours ago
Biotech, AI, and leveraged ETFs soar on corporate events and strong business updates

Biotech, AI, and leveraged ETFs soar on corporate events and strong business updates

Shares of Zhengye Biotechnology surged over 1047% to regain Nasdaq compliance after a minimum bid price warning. Advanced Biomed and Axe Compute also saw notable gains following a reverse stock split and Russell Microcap Index inclusion, respectively...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App